Adverse events204

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 204

Type	Event	Organ system	Group	Affected	At risk
other	Neutropenia	Blood and lymphatic system disorders	Cohort 1: Ixazomib 4.0 mg	6	7
other	Neutropenia	Blood and lymphatic system disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	5	7
other	Thrombocytopenia	Blood and lymphatic system disorders	Cohort 1: Ixazomib 4.0 mg	6	7
other	Thrombocytopenia	Blood and lymphatic system disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	4	7
other	Leukopenia	Blood and lymphatic system disorders	Cohort 1: Ixazomib 4.0 mg	5	7
other	Leukopenia	Blood and lymphatic system disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	4	7
other	Lymphopenia	Blood and lymphatic system disorders	Cohort 1: Ixazomib 4.0 mg	6	7
other	Lymphopenia	Blood and lymphatic system disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	2	7
other	Anaemia	Blood and lymphatic system disorders	Cohort 1: Ixazomib 4.0 mg	2	7
other	Anaemia	Blood and lymphatic system disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	1	7
other	Diarrhoea	Gastrointestinal disorders	Cohort 1: Ixazomib 4.0 mg	6	7
other	Diarrhoea	Gastrointestinal disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	4	7
other	Vomiting	Gastrointestinal disorders	Cohort 1: Ixazomib 4.0 mg	5	7
other	Vomiting	Gastrointestinal disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	3	7
other	Nausea	Gastrointestinal disorders	Cohort 1: Ixazomib 4.0 mg	5	7
other	Nausea	Gastrointestinal disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	2	7
other	Constipation	Gastrointestinal disorders	Cohort 1: Ixazomib 4.0 mg	1	7
other	Constipation	Gastrointestinal disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	2	7
other	Abdominal pain	Gastrointestinal disorders	Cohort 1: Ixazomib 4.0 mg	2	7
other	Abdominal pain	Gastrointestinal disorders	Cohort 2: Ixazomib 4.0 mg + Lenalidomide and Dexamethasone	0	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04272775/events

API reference For AI assistants

Adverse events204

Sources 3

Read this list from software.